Protection against chemotherapy induced mucositis by TG beta(2) in childhood cancer patients: Results from a randomized cross-over study

Barbara de Koning; B Philipsen-Geerling; M Hoijer; K Hahlen; HA (Hans) Buller; Rob Pieters

doi:10.1002/pbc.20910

Protection against chemotherapy induced mucositis by TG beta(2) in childhood cancer patients: Results from a randomized cross-over study

Barbara de Koning, B Philipsen-Geerling, M Hoijer, K Hahlen, HA (Hans) Buller, Rob Pieters

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

27 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	532-539
Number of pages	8
Journal	Pediatric Blood & Cancer
Volume	48
Issue number	5
DOIs	https://doi.org/10.1002/pbc.20910
Publication status	Published - 2007

Research programs

EMC MM-02-54-03

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/pbc.20910

http://hdl.handle.net/1765/37028

Cite this

@article{857f4e08e1094e07876caea5171a1983,

title = "Protection against chemotherapy induced mucositis by TG beta(2) in childhood cancer patients: Results from a randomized cross-over study",

author = "{de Koning}, Barbara and B Philipsen-Geerling and M Hoijer and K Hahlen and Buller, {HA (Hans)} and Rob Pieters",

year = "2007",

doi = "10.1002/pbc.20910",

language = "Undefined/Unknown",

volume = "48",

pages = "532--539",

journal = "Pediatric Blood & Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "5",

}

TY - JOUR

T1 - Protection against chemotherapy induced mucositis by TG beta(2) in childhood cancer patients: Results from a randomized cross-over study

AU - de Koning, Barbara

AU - Philipsen-Geerling, B

AU - Hoijer, M

AU - Hahlen, K

AU - Buller, HA (Hans)

AU - Pieters, Rob

PY - 2007

Y1 - 2007

U2 - 10.1002/pbc.20910

DO - 10.1002/pbc.20910

M3 - Article

C2 - 16767731

SN - 1545-5009

VL - 48

SP - 532

EP - 539

JO - Pediatric Blood & Cancer

JF - Pediatric Blood & Cancer

IS - 5

ER -